Paul Borchyung Yu MD PhD, FAHA
Director, Cardiovascular Research Center, Massachusetts General Hospital Charles Addison Sanders and Elizabeth Ann Sanders Endowed Chair Associate Professor of Medicine, Harvard Medical School
Join to View Full Profile
55 Fruit StBoston, MA 02114
Phone+1 617-726-2000
Dr. Yu is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Paul Yu is a cardiologist in Boston, MA and is affiliated with multiple hospitals in the area, including Massachusetts General Hospital and Brigham and Women's Hospital. He received his medical degree from Duke University School of Medicine and has been in practice 21 years. He is experienced in general cardiology and pulmonary hypertension.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Cardiovascular Disease, 2001 - 2006
University of California (San Francisco)Residency, Internal Medicine, 1999 - 2001
Duke University School of MedicineClass of 1999
Certifications & Licensure
MA State Medical License 2003 - 2028
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2017
Publications & Presentations
PubMed
- BMPR2 Dosage Gates BMP9/10 Signaling Output in Pulmonary Artery Endothelium.Kit-Yee Chu, Vijayalakshmi Thamilselvan, Amberly N Crawford, Paul B Yu, Erik Martinez-Hackert
Cells. 2026-03-10 - BMP9 Modulates IL-33 Signaling to Mitigate EndMT in Pulmonary Arterial Hypertension.Clarissa Becher, Esmee J Groeneveld, Rozenn Quarck, Beau Neep, Xiaoke Pan
Hypertension. 2026-02-01 - 2 citationsThe NOTCH3 extracellular domain is a serum biomarker for pulmonary arterial hypertension.Moises Hernandez, Nolan M Winicki, Cristian D Puerta, Swetha Lakshminarayanan, Yu Zhang
Nature Medicine. 2026-01-01
Press Mentions
Their Tissue Turns to Bone. Their Joints Freeze in Place. And, Finally, Their Hopes for Treatment May Be RealizedMarch 20th, 2019
Acceleron Announces Preclinical Results in Pulmonary Arterial Hypertension at the American Heart Association 2017 Scientific SessionsNovember 14th, 2017
In GeneralFebruary 12th, 2016
Grant Support
- Integrated, Multidisciplinary Training in Cardiovascular ResearchMASSACHUSETTS GENERAL HOSPITAL1993–2028
- Context-specific angiogenic signaling in the pulmonary vasculatureMASSACHUSETTS GENERAL HOSPITAL2021–2025
- Molecular and cellular mechanisms of heterotopic ossificationMASSACHUSETTS GENERAL HOSPITAL2010–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
